Cargando…

Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis

OBJECTIVES: Deoxyelephantopin (DET) is a kind of natural active ingredient extracted from the Chinese herbal medicine Elephantopus scaber L. Many studies have revealed the potential antitumor effect on multiple malignancies. However, the detailed mechanism of its antitumor effect in pancreatic cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Daolin, Hou, Li, Xie, Chunyang, Feng, Haonan, Bao, Dongdong, Teng, Yue, Liu, Junhao, Cui, Tiangang, Wang, Xiuhong, Xu, Yi, Tan, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252706/
https://www.ncbi.nlm.nih.gov/pubmed/35794978
http://dx.doi.org/10.1155/2022/3855462
_version_ 1784740327735689216
author Ji, Daolin
Hou, Li
Xie, Chunyang
Feng, Haonan
Bao, Dongdong
Teng, Yue
Liu, Junhao
Cui, Tiangang
Wang, Xiuhong
Xu, Yi
Tan, Gang
author_facet Ji, Daolin
Hou, Li
Xie, Chunyang
Feng, Haonan
Bao, Dongdong
Teng, Yue
Liu, Junhao
Cui, Tiangang
Wang, Xiuhong
Xu, Yi
Tan, Gang
author_sort Ji, Daolin
collection PubMed
description OBJECTIVES: Deoxyelephantopin (DET) is a kind of natural active ingredient extracted from the Chinese herbal medicine Elephantopus scaber L. Many studies have revealed the potential antitumor effect on multiple malignancies. However, the detailed mechanism of its antitumor effect in pancreatic cancer remains unclear. Recently, studies have confirmed that noncoding RNA (ncRNA) plays an important regulatory role in malignancies. This research was performed to explore the relationship between ncRNA and DET-induced tumor inhibition in pancreatic cancer. METHODS: Microarray profiling was applied to identify the candidate ncRNAs associated with DET-induced tumor inhibition. Quantitative real-time PCR was used to evaluate the expression of linc00511 in pancreatic cancer cells and tissues. The influence of DET on the cell proliferation, migration, and invasion was assessed by CCK-8, colony formation, wound healing, and Transwell assays. The relationship between lncRNAs, miRNAs, and p21 promoter region was analyzed by bioinformatics and verified by luciferase reporter gene and western blotting. The effect of linc00511 on nuclear translocation of miR-370-5p was explored by cytoplasmic and nuclear RNA purification. Moreover, the effect of DET on tumor growth and metastasis, and the prophylactic effect were investigated by establishing subcutaneous and lung metastatic tumor models. RESULTS: Microarray assay indicated linc00511 was a potential target gene. The antitumor effect of DET in pancreatic cancer depended on downregulating linc00511 expression, and linc00511 might be an oncogene in pancreatic cancer. Silencing linc00511 enhanced the antitumor function of DET; conversely, linc00511 overexpression antagonized the DET cytotoxic effect. Additionally, miR-370-5p could bind to p21 promoter to exert the RNA activation and then promote p21 expression. P21 was a downstream gene of linc00511 and associated with pancreatic cancer progression. Linc00511 regulated p21 expression by blocking miR-370-5p nuclear translocation. CONCLUSIONS: To sum up, the present finding confirmed that DET suppressed the malignant biological behavior of pancreatic cancer via linc00511/miR-370-5p/p21 promoter axis.
format Online
Article
Text
id pubmed-9252706
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92527062022-07-05 Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis Ji, Daolin Hou, Li Xie, Chunyang Feng, Haonan Bao, Dongdong Teng, Yue Liu, Junhao Cui, Tiangang Wang, Xiuhong Xu, Yi Tan, Gang J Oncol Research Article OBJECTIVES: Deoxyelephantopin (DET) is a kind of natural active ingredient extracted from the Chinese herbal medicine Elephantopus scaber L. Many studies have revealed the potential antitumor effect on multiple malignancies. However, the detailed mechanism of its antitumor effect in pancreatic cancer remains unclear. Recently, studies have confirmed that noncoding RNA (ncRNA) plays an important regulatory role in malignancies. This research was performed to explore the relationship between ncRNA and DET-induced tumor inhibition in pancreatic cancer. METHODS: Microarray profiling was applied to identify the candidate ncRNAs associated with DET-induced tumor inhibition. Quantitative real-time PCR was used to evaluate the expression of linc00511 in pancreatic cancer cells and tissues. The influence of DET on the cell proliferation, migration, and invasion was assessed by CCK-8, colony formation, wound healing, and Transwell assays. The relationship between lncRNAs, miRNAs, and p21 promoter region was analyzed by bioinformatics and verified by luciferase reporter gene and western blotting. The effect of linc00511 on nuclear translocation of miR-370-5p was explored by cytoplasmic and nuclear RNA purification. Moreover, the effect of DET on tumor growth and metastasis, and the prophylactic effect were investigated by establishing subcutaneous and lung metastatic tumor models. RESULTS: Microarray assay indicated linc00511 was a potential target gene. The antitumor effect of DET in pancreatic cancer depended on downregulating linc00511 expression, and linc00511 might be an oncogene in pancreatic cancer. Silencing linc00511 enhanced the antitumor function of DET; conversely, linc00511 overexpression antagonized the DET cytotoxic effect. Additionally, miR-370-5p could bind to p21 promoter to exert the RNA activation and then promote p21 expression. P21 was a downstream gene of linc00511 and associated with pancreatic cancer progression. Linc00511 regulated p21 expression by blocking miR-370-5p nuclear translocation. CONCLUSIONS: To sum up, the present finding confirmed that DET suppressed the malignant biological behavior of pancreatic cancer via linc00511/miR-370-5p/p21 promoter axis. Hindawi 2022-06-25 /pmc/articles/PMC9252706/ /pubmed/35794978 http://dx.doi.org/10.1155/2022/3855462 Text en Copyright © 2022 Daolin Ji et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ji, Daolin
Hou, Li
Xie, Chunyang
Feng, Haonan
Bao, Dongdong
Teng, Yue
Liu, Junhao
Cui, Tiangang
Wang, Xiuhong
Xu, Yi
Tan, Gang
Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
title Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
title_full Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
title_fullStr Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
title_full_unstemmed Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
title_short Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis
title_sort deoxyelephantopin suppresses pancreatic cancer progression in vitro and in vivo by targeting linc00511/mir-370-5p/p21 promoter axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252706/
https://www.ncbi.nlm.nih.gov/pubmed/35794978
http://dx.doi.org/10.1155/2022/3855462
work_keys_str_mv AT jidaolin deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT houli deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT xiechunyang deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT fenghaonan deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT baodongdong deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT tengyue deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT liujunhao deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT cuitiangang deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT wangxiuhong deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT xuyi deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis
AT tangang deoxyelephantopinsuppressespancreaticcancerprogressioninvitroandinvivobytargetinglinc00511mir3705pp21promoteraxis